Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04164173 · ClinicalTrials.gov registry record · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
A NA study of Pulmonary Disease and Postoperative Complications, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 324
- Enrollment target
- 1
- Study location
NCT04164173 is a NA study of Pulmonary Disease and Postoperative Complications that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 324 participants, below the 608-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04164173, a NA study of Pulmonary Disease and Postoperative Complications, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
Conditions Studied
Interventions
- DEVICE EzPAP
- DEVICE Metaneb
- DEVICE Intermittent Positive Pressure Breathing (IPPB)
Study Locations (1)
Texas
- UT Southwestern Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2020-06-15 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04164173
The ClinicalTrials.gov registry entry for NCT04164173 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (47% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Disease appearing as the primary indexed condition, and to 3 interventions - of which EzPAP is the first listed.
NCT04164173 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04164173 about?
NCT04164173 is a clinical study titled "Hyperinflation Respiratory Therapies in Cardiac Surgery Patients". The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation the...
What is the current status of trial NCT04164173?
This trial is currently recruiting. It is a NA study. The enrollment target is 324 participants. The study started on 2020-06-15. Estimated completion is 2028-12-31.
What conditions does trial NCT04164173 study?
This clinical trial studies the following conditions: Pulmonary Disease, Postoperative Complications.
What interventions are being tested in trial NCT04164173?
The interventions under investigation include: EzPAP (DEVICE), Metaneb (DEVICE), Intermittent Positive Pressure Breathing (IPPB) (DEVICE).
Who is sponsoring clinical trial NCT04164173?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04164173 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
ACTIVE NOT RECRUITING · NA
-
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
ACTIVE NOT RECRUITING · NA
-
Engineering Evaluation of the Helix Ventilator
COMPLETED · NA
-
High Flow vs Conventional Oxygen in Head and Neck Surgery
COMPLETED · NA
-
Cardiopulmonary Outpatient Rehabilitation Using Mobile Technology
COMPLETED · NA
-
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.